ERIS.NS Earnings — Eris Lifesciences Limited
NSE
Updated
When is ERIS.NS's next earnings date?
Eris Lifesciences Limited (ERIS.NS) has not announced its next earnings date yet. Its most recent earnings report was on Monday, October 26, 2026.
How did ERIS.NS do in its last earnings report?
In its most recent report on Oct 26, 2026, Eris Lifesciences Limited posted EPS of $13.30 versus the $10.62 estimate, a beat. Revenue was $8.85B against a $8.88B estimate.
How much does ERIS.NS stock move after earnings?
ERIS.NS beat EPS estimates in 1 of its last 2 reported quarters.
About Eris Lifesciences Limited
Eris Lifesciences Limited is an Indian pharmaceutical company engaged in the manufacturing, marketing, and distribution of medicinal products throughout the country. The company provides a comprehensive range of branded formulations, catering to a wide spectrum of therapeutic areas. These encompass cardiovascular health, anti-diabetic treatments, anti-infectives, antipyretics, vitamin/nutrient supplements, gastroenterology, respiratory care, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, alongside services in in-vitro fertilization, cosmetology, and dermatology. Founded in 2007, Eris Lifesciences Limited is headquartered in Ahmedabad, India.
🤖 AI Earnings Analysis
ERIS.NS trades at 23.3× earnings with a 19.8% profit margin; absent news or growth guidance, valuation alone offers no clear near-term catalyst.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-26 | 10.62 | 13.30 | — | $8.85B | ✅ Beat | — | — | — | |
| 2026-07-29 | 10.77 | 10.30 | — | $8.79B | ❌ Miss | — | — | — |
Showing last 2 quarters.